Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nyxoah ( (NYXH) ) just unveiled an update.
Nyxoah has announced a significant investment to expand its in-house manufacturing capacity in Wallonia, Belgium, as it scales up to meet growing demand for its obstructive sleep apnea therapy in the U.S. and abroad. The company has signed an agreement with life sciences business park LégiaPark in the Liège region to establish nearly 2,000 square meters of manufacturing space, including a state-of-the-art, scalable cleanroom designed with ABN Cleanroom Technology, strengthening its industrial base, improving gross margin potential and securing supply as sales ramp. The move deepens Nyxoah’s ties with the Belgian life sciences ecosystem and its strategic partnership with local investor Noshaq, underlining a strategy that combines international growth ambitions with a reinforced local presence and job creation in Belgium.
The most recent analyst rating on (NYXH) stock is a Buy with a EUR9.00 price target. To see the full list of analyst forecasts on Nyxoah stock, see the NYXH Stock Forecast page.
More about Nyxoah
Nyxoah is a Belgian medical technology company specializing in innovative neuromodulation solutions for obstructive sleep apnea (OSA), the most common sleep-disordered breathing condition linked to elevated mortality and cardiovascular risk. Its lead product, the Genio system, is a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy that has secured CE Mark approval in Europe, including for patients with Complete Concentric Collapse who are excluded from rival therapies, and U.S. FDA approval for a subset of adults with moderate to severe OSA. Listed on Euronext Brussels and Nasdaq following IPOs in 2020 and 2021, Nyxoah targets the global OSA treatment market with a focus on expanding its commercial footprint in the United States and international markets.
Average Trading Volume: 67,023
Current Market Cap: €177.1M
For an in-depth examination of NYXH stock, go to TipRanks’ Overview page.